Salary: 0-0K
Experience requirements: Experience is not limited
Educational requirements: Doctor and above
Job Description:
Shenzhen Bay Laboratory Li Zigang/Yin Feng Research Group Recruitment Announcement_x000D_
Brief introduction of Shenzhen Bay Laboratory_x000D_
Shenzhen Bay Laboratory (Life Information and Biomedicine Laboratory of Guangdong Province) is a major strategic plan for Guangdong Province and Shenzhen City to build an international science and technology innovation center and a comprehensive national science center in Guangdong, Hong Kong and Macao, and a major innovation carrier fully supported by Shenzhen in the construction of a pilot demonstration zone of socialism with Chinese characteristics._x000D_
Facing the world's scientific and technological frontiers and people's life and health, Shenzhen Bay Laboratory closely centers on the national strategic layout, takes the coordinated tackling of major scientific problems of life and health as its orientation, focuses on the prevention, diagnosis and treatment of major diseases such as cancer, metabolism and cardiovascular, neurodegenerative and infectious diseases, and takes the integration of IT + BT and interdisciplinary as its characteristics. To carry out research on disease mechanism, life information, innovative drugs, medical imaging and other fields. In the Shenzhen Bay Laboratory, major disease problems and frontier disciplines and technologies are the longitude and latitude of each other. The matrix design of scientific research units breaks the boundaries of traditional disciplines and fully promotes the advantages of interdisciplinary research. With the two-wheel drive of free exploration and collaborative research, the combination of scattered reconnaissance and position breakthrough, more comprehensive and accurate research on life and health issues is carried out, and the new mode of national system research is practiced._x000D_
The laboratory is committed to creating an efficient innovation system and a vigorous innovation ecosystem, creating a high-end technology support platform, promoting the transformation of research paradigms for efficient allocation of innovation elements, and stimulating the creativity of all kinds of talents. The laboratory gathers the advantages of life science, jointly builds a collaborative innovation community of Guangdong-Hong Kong-Macao Greater Bay Area, and strives to become an international first-class scientific and technological innovation highland._x000D_
Institute/Centre Profile_x000D_
Pingshan Biomedical Research and Development and Transformation Center of Shenzhen Bay Laboratory (hereinafter referred to as "Pingshan Center") is a second-class institution jointly established by Shenzhen Bay Laboratory and Pingshan People's Government, which is an important research and transformation window and pilot demonstration base, focusing on building new drug research and development platform, medical transformation platform, public technology service platform and nucleic acid. It is dedicated to providing first-class support service platform, pharmaceutical transformation platform and public technology service platform for pharmaceutical enterprises, R & D institutions and start-up teams Guangdong-Hong Kong-Macao Greater Bay Area._x000D_
New drug research and development platform: 1. Construction of chemical biology module, small molecule drug module and polypeptide protein drug module; 2. Exploration of new drug action mechanism, new drug action target and innovative drug research and development; 3. Development of a series of stable polypeptide regulators directly related to important human diseases in cells; 4. Using chemical biology and computational chemistry methods, combined with AI and other technologies, to study the interaction between drug molecules and targets._x000D_
Medicinal translational platform: ① anti-tumor targeted drugs of human cyclin-dependent kinase 9 inhibitor; ② new generation of anti-drug resistance anaplastic lymphoma kinase Type-I1/2 inhibitor; ③ targeted drugs for drug-resistant recurrent estrogen receptor-positive breast cancer; ④ targeted drugs for specific class I histone deacetylase._x000D_
Nucleic Acid Pharmaceutical Research Institute is an integral part of Shenzhen Bay Laboratory (Life Information and Biomedicine Guangdong Laboratory), which is managed by Pingshan Biomedical Research and Development Center. The purpose of the construction of the Institute of Nucleic Acid Drugs is to solve the basic theoretical or applied basic theoretical problems encountered in the research, development, transformation and production of nucleic acid drugs, and to promote major breakthroughs and original discoveries of nucleic acid drugs. Nowadays, the field of nucleic acid research is in an important period from the accumulation of quantity to the leap of quality and the breakthrough of point to the improvement of system capability. With the support of the research platform of * * *, Chinese scientists urgently need to pool their strength, aim at the world's difficult problems of nucleic acid research, seize the general trend and play the "first hand chess". Starting from the existing superior research direction in China, we will jointly develop and transform original nucleic acid drugs with Shenzhen Nucleic Acid Drug Conversion Production Base to serve China's biomedical research and development and social and economic development, aiming at leading the world's scientific and technological frontiers, adhering to the combination of basic and applied transformation, and facing the major needs of the country. It has become an innovative benchmark leading the development of life science in the world._x000D_
The main program directions of the Institute of Nucleic Acid Drugs include the following: 1) biological functions of typical extracellular non-coding RNAs and the possibility of drug preparation; 2) biological functions of long non-coding RNAs and circular RNAs and key issues of drug preparation; 3) modification and delivery of nucleic acid drugs; 4) new methods, new technologies and "no-man's land" exploration in the research of nucleic acid drugs; 5) exosome-based drug development; 6) third-generation nucleic acid drug delivery system, etc._x000D_
Brief introduction of the research group_x000D_
Project leader: Professor Li Zigang, PhD, University of Chicago, Dean, School of Chemistry and Biology, Shenzhen Graduate School, Peking University. His professional background is polypeptide synthesis and modification, and his research features are the structural optimization and molecular library construction of "stapler" polypeptides. He has accumulated profound research on the structure-activity relationship of lead compounds of polypeptide drugs. He is the technical core of several polypeptide cooperation projects, and is mainly engaged in protein engineering, organic synthesis, human disease treatment methods, organometallic chemistry and other fields. The application research direction of the team has many years of experience in stable polypeptide design and biological application transformation, featuring the development of chemical methods for novel stable polypeptides and biomedical application research._x000D_
Dr. Yin Feng, Head of the Research Group, Director of Biological Research Department and Cooperation Department of Pingshan Biomedical Research and Transformation Center, Shenzhen Bay Laboratory. He has been engaged in the application research of chemical biology and biomedicine of novel stable polypeptides for a long time and expanding the biomedical application of novel stable polypeptides. As a project leader, he has presided over five projects of the National Natural Science Foundation of China, the Post-doctoral Foundation and the Shenzhen Free Exploration Foundation, and participated in more than 10 national and provincial projects as a core member of the team. In the past five years, he has published more than 30 papers in international academic journals as * * * authors and corresponding authors. Published in Coordination Chemistry Reviews, Cancer Research, Theranostics, Chemical Science, Chemistry Communication and other international first-class academic journals._x000D_
Post: Postdoctoral (Cell Biology/Molecular Biology/Immunology)_x000D_
Number of people required: 2_x000D_
Job responsibilities:_x000D_
1. To carry out postdoctoral research in combination with the research direction of the research group;_x000D_
2. Independent or assistance in applying for vertical and horizontal scientific research projects;_x000D_
3. Other scientific research related tasks of the research group;_x000D_
Job requirements:_x000D_
1. Doctoral degree, under the age of 35;_x000D_
2. Cell biology, genomics, proteomics, metabolomics, immunology and other biology related majors;_x000D_
3. Love scientific research, have good scientific research ability and innovative thinking;_x000D_
4. Have good academic ethics, communication skills and team spirit, and diligent and serious working attitude;_x000D_
[Benefits]_x000D_
1. Salary: Provide competitive salary, the specific salary is negotiable according to the applicant's experience and qualifications, and those who meet the policy requirements can enjoy preferential personal income tax;_x000D_
2. Basic guarantee: pay five insurances and one housing fund according to the upper limit of payment proportion in Shenzhen, and enjoy national statutory holidays, paid annual leave and other holidays;_x000D_
3. Special benefits: annual health check-up for employees, supplementary medical insurance, free shuttle bus, employee activities, holiday greetings, etc;_x000D_
4. Scientific research environment: provide research conditions and working environment of international standards, including sufficient research funds, cutting-edge technology support platform, cross-border human resources, etc.;_x000D_
5. Talent incentive: the laboratory fully assists in applying for national, provincial, municipal, district, laboratory and other levels of talent plans, scientific research projects and related awards, subsidies or honorary titles;_x000D_
6. Life care: according to the regulations of Shenzhen and the laboratory, assist in settling down, applying for public rental housing and children's admission to kindergartens/schools._x000D_
In addition, qualified postdoctoral students will have the opportunity to participate in the selection of the "Fenji Postdoctoral" project set up by Shenzhen Bay Laboratory, and the outstanding postdoctoral students who are finally selected for the project will receive relevant living subsidies with an amount of 100000 yuan per person per year and a period of no more than 3 years. The Center provides postdoctoral students with a salary of * * * (including an annual subsidy of 180,000 yuan from the Shenzhen Municipal Government). There are additional performance bonuses based on scientific research results. If the postdoctoral students continue to work in Shenzhen after leaving the station, they can assist in applying for research grants (300000) for postdoctoral students to stay in Shenzhen.


Please send your CV or resume as an attachment to the following email address:
mailto: rbhr@hrcenter.co.uk
With the subject line formatted as: 'Name + Position + Company Name + Location'.

Salary: 0-0K
Experience requirements: Experience is not limited
Educational requirements: Doctor and above
Job Description:
Shenzhen Bay Laboratory Li Zigang/Yin Feng Research Group Recruitment Announcement_x000D_
Brief introduction of Shenzhen Bay Laboratory_x000D_
Shenzhen Bay Laboratory (Life Information and Biomedicine Laboratory of Guangdong Province) is a major strategic plan for Guangdong Province and Shenzhen City to build an international science and technology innovation center and a comprehensive national science center in Guangdong, Hong Kong and Macao, and a major innovation carrier fully supported by Shenzhen in the construction of a pilot demonstration zone of socialism with Chinese characteristics._x000D_
Facing the world's scientific and technological frontiers and people's life and health, Shenzhen Bay Laboratory closely centers on the national strategic layout, takes the coordinated tackling of major scientific problems of life and health as its orientation, focuses on the prevention, diagnosis and treatment of major diseases such as cancer, metabolism and cardiovascular, neurodegenerative and infectious diseases, and takes the integration of IT + BT and interdisciplinary as its characteristics. To carry out research on disease mechanism, life information, innovative drugs, medical imaging and other fields. In the Shenzhen Bay Laboratory, major disease problems and frontier disciplines and technologies are the longitude and latitude of each other. The matrix design of scientific research units breaks the boundaries of traditional disciplines and fully promotes the advantages of interdisciplinary research. With the two-wheel drive of free exploration and collaborative research, the combination of scattered reconnaissance and position breakthrough, more comprehensive and accurate research on life and health issues is carried out, and the new mode of national system research is practiced._x000D_
The laboratory is committed to creating an efficient innovation system and a vigorous innovation ecosystem, creating a high-end technology support platform, promoting the transformation of research paradigms for efficient allocation of innovation elements, and stimulating the creativity of all kinds of talents. The laboratory gathers the advantages of life science, jointly builds a collaborative innovation community of Guangdong-Hong Kong-Macao Greater Bay Area, and strives to become an international first-class scientific and technological innovation highland._x000D_
Institute/Centre Profile_x000D_
Pingshan Biomedical Research and Development and Transformation Center of Shenzhen Bay Laboratory (hereinafter referred to as "Pingshan Center") is a second-class institution jointly established by Shenzhen Bay Laboratory and Pingshan People's Government, which is an important research and transformation window and pilot demonstration base, focusing on building new drug research and development platform, medical transformation platform, public technology service platform and nucleic acid. It is dedicated to providing first-class support service platform, pharmaceutical transformation platform and public technology service platform for pharmaceutical enterprises, R & D institutions and start-up teams Guangdong-Hong Kong-Macao Greater Bay Area._x000D_
New drug research and development platform: 1. Construction of chemical biology module, small molecule drug module and polypeptide protein drug module; 2. Exploration of new drug action mechanism, new drug action target and innovative drug research and development; 3. Development of a series of stable polypeptide regulators directly related to important human diseases in cells; 4. Using chemical biology and computational chemistry methods, combined with AI and other technologies, to study the interaction between drug molecules and targets._x000D_
Medicinal translational platform: ① anti-tumor targeted drugs of human cyclin-dependent kinase 9 inhibitor; ② new generation of anti-drug resistance anaplastic lymphoma kinase Type-I1/2 inhibitor; ③ targeted drugs for drug-resistant recurrent estrogen receptor-positive breast cancer; ④ targeted drugs for specific class I histone deacetylase._x000D_
Nucleic Acid Pharmaceutical Research Institute is an integral part of Shenzhen Bay Laboratory (Life Information and Biomedicine Guangdong Laboratory), which is managed by Pingshan Biomedical Research and Development Center. The purpose of the construction of the Institute of Nucleic Acid Drugs is to solve the basic theoretical or applied basic theoretical problems encountered in the research, development, transformation and production of nucleic acid drugs, and to promote major breakthroughs and original discoveries of nucleic acid drugs. Nowadays, the field of nucleic acid research is in an important period from the accumulation of quantity to the leap of quality and the breakthrough of point to the improvement of system capability. With the support of the research platform of * * *, Chinese scientists urgently need to pool their strength, aim at the world's difficult problems of nucleic acid research, seize the general trend and play the "first hand chess". Starting from the existing superior research direction in China, we will jointly develop and transform original nucleic acid drugs with Shenzhen Nucleic Acid Drug Conversion Production Base to serve China's biomedical research and development and social and economic development, aiming at leading the world's scientific and technological frontiers, adhering to the combination of basic and applied transformation, and facing the major needs of the country. It has become an innovative benchmark leading the development of life science in the world._x000D_
The main program directions of the Institute of Nucleic Acid Drugs include the following: 1) biological functions of typical extracellular non-coding RNAs and the possibility of drug preparation; 2) biological functions of long non-coding RNAs and circular RNAs and key issues of drug preparation; 3) modification and delivery of nucleic acid drugs; 4) new methods, new technologies and "no-man's land" exploration in the research of nucleic acid drugs; 5) exosome-based drug development; 6) third-generation nucleic acid drug delivery system, etc._x000D_
Brief introduction of the research group_x000D_
Project leader: Professor Li Zigang, PhD, University of Chicago, Dean, School of Chemistry and Biology, Shenzhen Graduate School, Peking University. His professional background is polypeptide synthesis and modification, and his research features are the structural optimization and molecular library construction of "stapler" polypeptides. He has accumulated profound research on the structure-activity relationship of lead compounds of polypeptide drugs. He is the technical core of several polypeptide cooperation projects, and is mainly engaged in protein engineering, organic synthesis, human disease treatment methods, organometallic chemistry and other fields. The application research direction of the team has many years of experience in stable polypeptide design and biological application transformation, featuring the development of chemical methods for novel stable polypeptides and biomedical application research._x000D_
Dr. Yin Feng, Head of the Research Group, Director of Biological Research Department and Cooperation Department of Pingshan Biomedical Research and Transformation Center, Shenzhen Bay Laboratory. He has been engaged in the application research of chemical biology and biomedicine of novel stable polypeptides for a long time and expanding the biomedical application of novel stable polypeptides. As a project leader, he has presided over five projects of the National Natural Science Foundation of China, the Post-doctoral Foundation and the Shenzhen Free Exploration Foundation, and participated in more than 10 national and provincial projects as a core member of the team. In the past five years, he has published more than 30 papers in international academic journals as * * * authors and corresponding authors. Published in Coordination Chemistry Reviews, Cancer Research, Theranostics, Chemical Science, Chemistry Communication and other international first-class academic journals._x000D_
Post: Postdoctoral (Cell Biology/Molecular Biology/Immunology)_x000D_
Number of people required: 2_x000D_
Job responsibilities:_x000D_
1. To carry out postdoctoral research in combination with the research direction of the research group;_x000D_
2. Independent or assistance in applying for vertical and horizontal scientific research projects;_x000D_
3. Other scientific research related tasks of the research group;_x000D_
Job requirements:_x000D_
1. Doctoral degree, under the age of 35;_x000D_
2. Cell biology, genomics, proteomics, metabolomics, immunology and other biology related majors;_x000D_
3. Love scientific research, have good scientific research ability and innovative thinking;_x000D_
4. Have good academic ethics, communication skills and team spirit, and diligent and serious working attitude;_x000D_
[Benefits]_x000D_
1. Salary: Provide competitive salary, the specific salary is negotiable according to the applicant's experience and qualifications, and those who meet the policy requirements can enjoy preferential personal income tax;_x000D_
2. Basic guarantee: pay five insurances and one housing fund according to the upper limit of payment proportion in Shenzhen, and enjoy national statutory holidays, paid annual leave and other holidays;_x000D_
3. Special benefits: annual health check-up for employees, supplementary medical insurance, free shuttle bus, employee activities, holiday greetings, etc;_x000D_
4. Scientific research environment: provide research conditions and working environment of international standards, including sufficient research funds, cutting-edge technology support platform, cross-border human resources, etc.;_x000D_
5. Talent incentive: the laboratory fully assists in applying for national, provincial, municipal, district, laboratory and other levels of talent plans, scientific research projects and related awards, subsidies or honorary titles;_x000D_
6. Life care: according to the regulations of Shenzhen and the laboratory, assist in settling down, applying for public rental housing and children's admission to kindergartens/schools._x000D_
In addition, qualified postdoctoral students will have the opportunity to participate in the selection of the "Fenji Postdoctoral" project set up by Shenzhen Bay Laboratory, and the outstanding postdoctoral students who are finally selected for the project will receive relevant living subsidies with an amount of 100000 yuan per person per year and a period of no more than 3 years. The Center provides postdoctoral students with a salary of * * * (including an annual subsidy of 180,000 yuan from the Shenzhen Municipal Government). There are additional performance bonuses based on scientific research results. If the postdoctoral students continue to work in Shenzhen after leaving the station, they can assist in applying for research grants (300000) for postdoctoral students to stay in Shenzhen.


Please send your CV or resume as an attachment to the following email address:
mailto: rbhr@hrcenter.co.uk
With the subject line formatted as: 'Name + Position + Company Name + Location'.